134 related articles for article (PubMed ID: 33279861)
1. Longitudinal plasma protein profiling of newly diagnosed type 2 diabetes.
Gummesson A; Björnson E; Fagerberg L; Zhong W; Tebani A; Edfors F; Schmidt C; Lundqvist A; Adiels M; Bäckhed F; Schwenk JM; Jansson PA; Uhlén M; Bergström G
EBioMedicine; 2021 Jan; 63():103147. PubMed ID: 33279861
[TBL] [Abstract][Full Text] [Related]
2. Facets of individual-specific health signatures determined from longitudinal plasma proteome profiling.
Dodig-Crnković T; Hong MG; Thomas CE; Häussler RS; Bendes A; Dale M; Edfors F; Forsström B; Magnusson PKE; Schuppe-Koistinen I; Odeberg J; Fagerberg L; Gummesson A; Bergström G; Uhlén M; Schwenk JM
EBioMedicine; 2020 Jul; 57():102854. PubMed ID: 32629387
[TBL] [Abstract][Full Text] [Related]
3. Next generation plasma proteome profiling to monitor health and disease.
Zhong W; Edfors F; Gummesson A; Bergström G; Fagerberg L; Uhlén M
Nat Commun; 2021 May; 12(1):2493. PubMed ID: 33941778
[TBL] [Abstract][Full Text] [Related]
4. Proteomic and bioinformatic analysis of membrane proteome in type 2 diabetic mouse liver.
Kim GH; Park EC; Yun SH; Hong Y; Lee DG; Shin EY; Jung J; Kim YH; Lee KB; Jang IS; Lee ZW; Chung YH; Choi JS; Cheong C; Kim S; Kim SI
Proteomics; 2013 Apr; 13(7):1164-79. PubMed ID: 23349036
[TBL] [Abstract][Full Text] [Related]
5. Plasma Proteome Profiling Reveals Dynamics of Inflammatory and Lipid Homeostasis Markers after Roux-En-Y Gastric Bypass Surgery.
Wewer Albrechtsen NJ; Geyer PE; Doll S; Treit PV; Bojsen-Møller KN; Martinussen C; Jørgensen NB; Torekov SS; Meier F; Niu L; Santos A; Keilhauer EC; Holst JJ; Madsbad S; Mann M
Cell Syst; 2018 Dec; 7(6):601-612.e3. PubMed ID: 30528273
[TBL] [Abstract][Full Text] [Related]
6. Next generation plasma proteome profiling of COVID-19 patients with mild to moderate symptoms.
Zhong W; Altay O; Arif M; Edfors F; Doganay L; Mardinoglu A; Uhlen M; Fagerberg L
EBioMedicine; 2021 Dec; 74():103723. PubMed ID: 34844191
[TBL] [Abstract][Full Text] [Related]
7. A heterogeneous response of liver and skeletal muscle fat to the combination of a Paleolithic diet and exercise in obese individuals with type 2 diabetes: a randomised controlled trial.
Otten J; Stomby A; Waling M; Isaksson A; Söderström I; Ryberg M; Svensson M; Hauksson J; Olsson T
Diabetologia; 2018 Jul; 61(7):1548-1559. PubMed ID: 29696296
[TBL] [Abstract][Full Text] [Related]
8. Predictive biomarkers for type 2 of diabetes mellitus: Bridging the gap between systems research and personalized medicine.
Kraniotou C; Karadima V; Bellos G; Tsangaris GT
J Proteomics; 2018 Sep; 188():59-62. PubMed ID: 29518575
[TBL] [Abstract][Full Text] [Related]
9. Mining of protein based biomarkers for type 2 diabetes mellitus.
Khan AR; Awan FR
Pak J Pharm Sci; 2012 Oct; 25(4):889-901. PubMed ID: 23010011
[TBL] [Abstract][Full Text] [Related]
10. Plasma proteome changes in subjects with Type 2 diabetes mellitus with a low or high early insulin response.
Sundsten T; Zethelius B; Berne C; Bergsten P
Clin Sci (Lond); 2008 Apr; 114(7):499-507. PubMed ID: 17961122
[TBL] [Abstract][Full Text] [Related]
11. Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.
Smith JG; Gerszten RE
Circulation; 2017 Apr; 135(17):1651-1664. PubMed ID: 28438806
[TBL] [Abstract][Full Text] [Related]
12. Temporal expression profiling of plasma proteins reveals oxidative stress in early stages of Type 1 Diabetes progression.
Liu CW; Bramer L; Webb-Robertson BJ; Waugh K; Rewers MJ; Zhang Q
J Proteomics; 2018 Feb; 172():100-110. PubMed ID: 28993202
[TBL] [Abstract][Full Text] [Related]
13. Temporal profiles of plasma proteome during childhood development.
Liu CW; Bramer L; Webb-Robertson BJ; Waugh K; Rewers MJ; Zhang Q
J Proteomics; 2017 Jan; 152():321-328. PubMed ID: 27890796
[TBL] [Abstract][Full Text] [Related]
14. Water T
Robinson MD; Mishra I; Deodhar S; Patel V; Gordon KV; Vintimilla R; Brown K; Johnson L; O'Bryant S; Cistola DP
J Transl Med; 2017 Dec; 15(1):258. PubMed ID: 29258604
[TBL] [Abstract][Full Text] [Related]
15. Quantitative Comparative Proteomics Reveals Candidate Biomarkers for the Early Prediction of Gestational Diabetes Mellitus: A Preliminary Study.
Mavreli D; Evangelinakis N; Papantoniou N; Kolialexi A
In Vivo; 2020; 34(2):517-525. PubMed ID: 32111749
[TBL] [Abstract][Full Text] [Related]
16. Proteomics reveals the effects of sustained weight loss on the human plasma proteome.
Geyer PE; Wewer Albrechtsen NJ; Tyanova S; Grassl N; Iepsen EW; Lundgren J; Madsbad S; Holst JJ; Torekov SS; Mann M
Mol Syst Biol; 2016 Dec; 12(12):901. PubMed ID: 28007936
[TBL] [Abstract][Full Text] [Related]
17. Association of serum Sestrin2 level with metabolic risk factors in newly diagnosed drug-naïve type 2 diabetes.
Chung HS; Hwang HJ; Hwang SY; Kim NH; Seo JA; Kim SG; Kim NH; Baik SH; Choi KM; Yoo HJ
Diabetes Res Clin Pract; 2018 Oct; 144():34-41. PubMed ID: 30099048
[TBL] [Abstract][Full Text] [Related]
18. Quantitative proteomic analysis of human plasma using tandem mass tags to identify novel biomarkers for herpes zoster.
Wang T; Shen H; Deng H; Pan H; He Q; Ni H; Tao J; Liu S; Xu L; Yao M
J Proteomics; 2020 Aug; 225():103879. PubMed ID: 32585426
[TBL] [Abstract][Full Text] [Related]
19. The effect of a novel probiotic on metabolic biomarkers in adults with prediabetes and recently diagnosed type 2 diabetes mellitus: study protocol for a randomized controlled trial.
Palacios T; Vitetta L; Coulson S; Madigan CD; Denyer GS; Caterson ID
Trials; 2017 Jan; 18(1):7. PubMed ID: 28069054
[TBL] [Abstract][Full Text] [Related]
20. Localized-statistical quantification of human serum proteome associated with type 2 diabetes.
Li RX; Chen HB; Tu K; Zhao SL; Zhou H; Li SJ; Dai J; Li QR; Nie S; Li YX; Jia WP; Zeng R; Wu JR
PLoS One; 2008 Sep; 3(9):e3224. PubMed ID: 18795103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
